Related Experiment Videos

First person - Hartmut Cuny

    Disease Models & Mechanisms
    |November 14, 2022
    PubMed

    Insights

    Maternal heterozygosity of the Slc6a19 gene in mice leads to metabolic issues and congenital nicotinamide adenine dinucleotide (NAD) deficiency disorder. This research highlights the gene

    Area of Science:

    • Developmental Biology
    • Genetics
    • Metabolic Disorders

    Background:

    • Congenital malformations have complex genetic and environmental causes.
    • The Slc6a19 gene plays a role in nutrient transport and metabolism.
    • Nicotinamide adenine dinucleotide (NAD) is crucial for cellular energy and function.

    Purpose of the Study:

    • To investigate the impact of maternal Slc6a19 heterozygosity on offspring development and metabolism.
    • To characterize the resulting congenital disorder in mice.
    • To understand the link between Slc6a19 and NAD deficiency.

    Main Methods:

    • Mice models with maternal Slc6a19 heterozygosity were generated.
    • Metabolic profiles and NAD levels were assessed in affected offspring.
    • Genetic and biochemical analyses were performed.

    Main Results:

    • Maternal Slc6a19 heterozygosity caused significant metabolic perturbations in offspring.
    • Affected mice exhibited congenital nicotinamide adenine dinucleotide (NAD) deficiency disorder.
    • Slc6a19 deficiency was directly linked to impaired NAD synthesis or utilization.

    Conclusions:

    • Maternal Slc6a19 heterozygosity is a cause of congenital NAD deficiency disorder in mice.
    • This finding reveals a novel genetic cause for congenital metabolic disorders.
    • Understanding Slc6a19's role is critical for addressing developmental metabolic diseases.

    Related Concept Videos